{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:55:20Z","timestamp":1792652120695,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012895","name":"Zoetis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Administration of four to six consecutive monthly doses of 24\u00a0\u00b5g\/kg moxidectin alone shows high effectiveness in preventing the maturation of macrocyclic lactone (ML)-resistant heartworm strains, <jats:italic>Dirofilaria immitis<\/jats:italic> JYD-34 and ZoeLA. This laboratory study evaluated the efficacy of six consecutive monthly oral doses of Simparica Trio<jats:sup>\u00ae<\/jats:sup> (moxidectin\/sarolaner\/pyrantel) compared to six monthly doses of either Heartgard<jats:sup>\u00ae<\/jats:sup> Plus (ivermectin\/pyrantel) or Interceptor<jats:sup>\u00ae<\/jats:sup> Plus (milbemycin oxime\/praziquantel) against ML-resistant <jats:italic>D. immitis<\/jats:italic> ZoeLA strain.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Beagle dogs were inoculated with 50 third-stage (L3) <jats:italic>D. immitis<\/jats:italic> larvae (ZoeLA) 30\u00a0days prior to the first treatment. Dogs were randomized to treatment (six animals in each group) with six monthly oral doses of placebo, Simparica Trio, Heartgard Plus, or Interceptor Plus at their respective label doses. Microfilaria (MF) and antigen tests were conducted periodically, and efficacy was evaluated by necropsy for adult heartworms approximately 9 months after L3 inoculation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Adult heartworms were recovered from all six placebo dogs, with a geometric mean of 35.5 worms (range, 23\u201348). Five of the six dogs treated with Simparica Trio were infected with a geometric mean of 1.0 worms (range, 0\u20133), and all remained MF-negative. All Heartgard Plus-treated dogs (six) were infected with a geometric mean of 32.5 worms (range, 22\u201338); five of these dogs were MF-positive at day 236. All Interceptor Plus-treated dogs (six) were infected with a geometric mean of 22.8 worms (range, 10\u201334); five of these dogs were MF-positive at day 236. The efficacy of six consecutive doses with Simparica Trio, Heartgard Plus, and Interceptor Plus against ZoeLA was 97.2, 8.5, and 35.9%, respectively. Adult worm counts for the Simparica Trio-treated group were significantly lower (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) than placebo control, Heartgard Plus, and Interceptor Plus-treated groups. Adult worm counts for Heartgard Plus and Interceptor Plus were not significantly different from placebo (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Simparica Trio prevented microfilaremia in all dogs and was highly effective (97.2%) and significantly better than either Heartgard Plus (8.5%) or Interceptor Plus (35.9%) in preventing the development of the ZoeLA ML-resistant heartworm strain when administered for six consecutive months in this comparative laboratory efficacy study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13071-022-05180-3","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T12:09:09Z","timestamp":1647000549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Preventive efficacy of six monthly oral doses of Simparica Trio\u00ae, Heartgard\u00ae Plus, and Interceptor\u00ae Plus against a macrocyclic lactone-resistant strain (ZoeLA) of heartworm (Dirofilaria immitis) in dogs"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5348-848X","authenticated-orcid":false,"given":"Jamie A. E.","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Holzmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"McCall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Mahabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom L.","family":"McTier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Maeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Kryda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,11]]},"reference":[{"key":"5180_CR1","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cvsm.2009.06.003","volume":"39","author":"DD Bowman","year":"2009","unstructured":"Bowman DD, Atkins CE. Heartworm biology, treatment, and control. Vet Clin Small Anim. 2009;39:1127\u201358.","journal-title":"Vet Clin Small Anim"},{"key":"5180_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13071-018-2631-0","volume":"11","author":"J Drake","year":"2018","unstructured":"Drake J, Wiseman S. Increasing incidence of Dirofilaria immitis in dogs in USA with focus on the southeast region 2013\u20132016. Parasit Vectors. 2018;11:39.","journal-title":"Parasit Vectors"},{"key":"5180_CR3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/1756-3305-7-206","volume":"7","author":"C Genchi","year":"2014","unstructured":"Genchi C, Bowman DD, Drake J. Canine heartworm disease (Dirofilaria immitis) in western Europe: survey of veterinary awareness and perceptions. Parasit Vectors. 2014;7:206.","journal-title":"Parasit Vectors"},{"key":"5180_CR4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s13071-019-3685-3","volume":"12","author":"TL McTier","year":"2019","unstructured":"McTier TL, Six RH, Pullins A, Chapin S, Kryda K, Mahabir SP, et al. Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs. Parasit Vectors. 2019;12:444.","journal-title":"Parasit Vectors"},{"key":"5180_CR5","unstructured":"American Heartworm Society. Current canine guidelines for the prevention, diagnosis and management of heartworm (Dirofilaria immitis) infection in dogs (revised 2018). https:\/\/d3ft8sckhnqim2.cloudfront.net\/images\/pdf\/2018-AHS-Canine-Guidelines-181114.pdf?1542248135. Accessed 1 Sep 2021."},{"key":"5180_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.vetpar.2014.01.007","volume":"203","author":"SE Little","year":"2014","unstructured":"Little SE, Munzing C, Heise SR, Allen KE, Starkey LA, Johnson EM, et al. Pre-treatment with heat facilitates detection of antigen of Dirofilaria immitis in canine samples. Vet Parasitol. 2014;203:250\u20132.","journal-title":"Vet Parasitol"},{"key":"5180_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-016-1476-7","volume":"9","author":"BL Blagburn","year":"2016","unstructured":"Blagburn BL, Arther RG, Dillon AR, Butler JM, Bowles JV, von Simson C, et al. Efficacy of four commercially available heartworm preventive products against the JYD-34 laboratory strain of Dirofilaria immitis. Parasit Vectors. 2016;9:1\u201310. https:\/\/doi.org\/10.1186\/s13071-016-1476-7.","journal-title":"Parasit Vectors"},{"key":"5180_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.vetpar.2015.04.002","volume":"210","author":"C Bourguinat","year":"2015","unstructured":"Bourguinat C, Lee ACY, Lizundia R, et al. Macrocyclic lactone resistance in Dirofilaria immitis: Failure of heartworm preventives and investigation of genetic markers for resistance. Vet Parasitol. 2015;210:167\u201378. https:\/\/doi.org\/10.1016\/j.vetpar.2015.04.002.","journal-title":"Vet Parasitol"},{"key":"5180_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-019-3862-4","volume":"13","author":"K Kryda","year":"2020","unstructured":"Kryda K, Holzmer S, Everett WR, McCall JW, Mahabir SP, McTier T, et al. Preventive efficacy of four or six monthly oral doses of 24 \u00b5g\/kg moxidectin compared to six monthly doses of Heartgard\u00ae Plus or Interceptor\u00ae Plus against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs. Parasit Vectors. 2020;13:1\u201311.","journal-title":"Parasit Vectors"},{"key":"5180_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13071-021-04708-3","volume":"14","author":"TL McTier","year":"2021","unstructured":"McTier TL, Holzmer S, Kryda K, Mahabir S, McCall JW, Trombley J, et al. Comparative preventive efficacy of ProHeart\u00ae 12, Heartgard\u00ae Plus and Interceptor\u00ae Plus against a macrocyclic lactone-resistant strain (JYD-34) of heartworm (Dirofilaria immitis) in dogs. Parasit Vectors. 2021;14:226.","journal-title":"Parasit Vectors"},{"key":"5180_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijpddr.2019.06.002","volume":"10","author":"RK Prichard","year":"2019","unstructured":"Prichard RK, Geary TG. Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance. Int J Parasitol Drugs Drug Resist. 2019;10:69\u201383.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5180_CR12","unstructured":"Center for Veterinary Medicine. Guidance for industry. Effectiveness of anthelmintics: general recommendations, VICH GL7. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/cvm-gfi-90-vich-gl7-effectiveness-anthelmintics-general-recommendations. Accessed 1 Sep 2021."},{"key":"5180_CR13","unstructured":"Center for Veterinary Medicine. Guidance for industry. Effectiveness of anthelmintics: specific recommendations for canine, VICH GL19. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/cvm-gfi-111-vich-gl19-effectiveness-anthelmintics-specific-recommendations-canine. Accessed 1 Sep 2021."},{"key":"5180_CR14","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s13071-017-2429-5","volume":"10","author":"TL McTier","year":"2017","unstructured":"McTier TL, Six RH, Pullins A, Chapin S, McCall JW, Rugg D, et al. Efficacy of oral moxidectin against susceptible and resistant isolates of Dirofilaria immitis in dogs. Parasit Vectors. 2017;10:482.","journal-title":"Parasit Vectors"},{"key":"5180_CR15","unstructured":"McCall JW, Lindemann BA, Porter CA. Prophylactic activity of avermectins against experimentally induced Dirofilaria immitis in dogs. In: Proceedings of the heartworm symposium \u02bc80. Edwardsville: Veterinary Medicine Publishing Co.;1980 p. 126\u201330."},{"key":"5180_CR16","first-page":"1341","volume":"47","author":"RA Holmes","year":"1986","unstructured":"Holmes RA, McCall JW, Prasse KW. Thiacetarsamide in dogs with Dirofilaria immitis: influence of decreased liver function on drug efficacy. Am J Vet Res. 1986;47:1341\u20134.","journal-title":"Am J Vet Res"},{"key":"5180_CR17","first-page":"133","volume":"30","author":"H Hoch","year":"2008","unstructured":"Hoch H, Strickland K. Canine and feline dirofilariasis: life cycle, pathophysiology, and diagnosis. Compend Contin Educ Vet. 2008;30:133\u201340.","journal-title":"Compend Contin Educ Vet"},{"key":"5180_CR18","unstructured":"Venco, L. Heartworm (Dirofilaria immitis) disease in dogs. International veterinary information service. http:\/\/www.ivis.org\/proceedings\/dirofilaria\/2007\/venco1.pdf. Accessed 17 Oct 2019."},{"key":"5180_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0065-308X(08)00204-2","volume":"66","author":"JW McCall","year":"2008","unstructured":"McCall JW, Genchi C, Kramer LH, Guerrero J, Venco L. Heartworm disease in animals and humans. Adv Parasitol. 2008;66:193\u2013285.","journal-title":"Adv Parasitol"},{"key":"5180_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s13071-019-3702-6","volume":"12","author":"K Kryda","year":"2019","unstructured":"Kryda K, Six RH, Walsh KF, Holzmer SJ, Mahabir SP, Myers M, et al. Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs. Parasit Vectors. 2019;12:445.","journal-title":"Parasit Vectors"},{"key":"5180_CR21","unstructured":"Blagburn BL, Vaughan JL, Butler JM, Mount JD, Spencer JA, Carmichael J, Schenker R. Evaluation of susceptibility of heartworm (Dirofilaria immitis) biotypes to macrocyclic lactones using microfilariae-based single dose and dose-mortality regression assays. Proceedings of the AAVP 56th Annual Meeting, 16\u201319 July 2011, St. Louis, MO, USA; 2011."},{"key":"5180_CR22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.vetpar.2011.04.012","volume":"181","author":"C Bourguinat","year":"2011","unstructured":"Bourguinat C, Keller K, Bhan A, Peregrine A, Geary T, Prichard R. Macrocyclic lactone resistance in Dirofilaria immitis. Vet Parastiol. 2011;181:388\u201392.","journal-title":"Vet Parastiol"},{"key":"5180_CR23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s13071-019-3632-3","volume":"12","author":"TL McTier","year":"2019","unstructured":"McTier TL, Kryda K, Wachowski M, Mahabir SP, Ramsey D, Rugg D, et al. ProHeart\u00ae 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months. Parasit Vectors. 2019;12:369.","journal-title":"Parasit Vectors"},{"key":"5180_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-017-2047-2","volume":"10","author":"B Serrano-Parre\u00f1o","year":"2017","unstructured":"Serrano-Parre\u00f1o B, Carret\u00f3n E, Caro-Vadillo A, Falc\u00f3n-Cord\u00f3n Y, Falc\u00f3n-Cord\u00f3n S, Montoya-Alonso JA. Evaluation of pulmonary hypertension and clinical status in dogs with heartworm by Right Pulmonary Artery Distensibility Index and other echocardiographic parameters. Parasit Vectors. 2017;10:1\u20136.","journal-title":"Parasit Vectors"},{"key":"5180_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.vetpar.2014.08.013","volume":"206","author":"CE Atkins","year":"2014","unstructured":"Atkins CE, Murray MJ, Olavessen LJ, Burton KW, Marshall JW, Brooks CC. Heartworm \u2018lack of effectiveness\u2019 claims in the Mississippi delta: Computerized analysis of owner compliance\u20142004\u20132011. Vet Parastiol. 2014;206:106\u201313.","journal-title":"Vet Parastiol"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-022-05180-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-022-05180-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-022-05180-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T12:13:52Z","timestamp":1647000832000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-022-05180-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,11]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["5180"],"URL":"https:\/\/doi.org\/10.1186\/s13071-022-05180-3","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,11]]},"assertion":[{"value":"1 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the study site\u2019s Institutional Animal Care and Use Committee prior to implementation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study was funded by Zoetis, Parsipanny, NJ, USA. JAEM, SH, SPM, TM, SJM, and KK were employees of Zoetis. JWM was the contracted study investigator.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}